Evidence map›Paper›PMID 26301565›Full record

ArticleNature immunology2015

Histone reader BRWD1 targets and restricts recombination to the Igk locus.

Malay Mandal, Keith M Hamel, Mark Maienschein-Cline, Azusa Tanaka, Grace Teng, Jigyasa H Tuteja, Jeffrey J Bunker, Neil Bahroos, John J Eppig, David G Schatz and 1 more

Open access · greenAbstract read
In one paragraph

Article in Nature immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Alterations in chromatin at antigen receptor loci define lineage progression during B lymphopoiesis.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Malay MandalDepartment of Medicine, Section of Rheumatology and Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, Chicago, Illinois, USA.
Keith M HamelDepartment of Medicine, Section of Rheumatology and Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, Chicago, Illinois, USA.
Mark Maienschein-ClineCenter for Research Informatics, University of Illinois at Chicago, Chicago, Illinois, USA.
Azusa TanakaDepartment of Medicine, Section of Rheumatology and Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, Chicago, Illinois, USA.
Grace TengDepartment of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.
Jigyasa H TutejaDepartment of Human Genetics, Institute for Genomics and Systems Biology, University of Chicago, Chicago, Illinois, USA.
Jeffrey J BunkerDepartment of Pathology, University of Chicago, Chicago, Illinois, USA.ORCID http://orcid.org/0000-0002-9351-7003
Neil BahroosCenter for Research Informatics, University of Illinois at Chicago, Chicago, Illinois, USA.
John J EppigReproductive Biology, The Jackson Laboratory, Bar Harbor, Maine, USA.
David G SchatzDepartment of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.
Marcus R ClarkDepartment of Medicine, Section of Rheumatology and Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, Chicago, Illinois, USA.
University of Chicago · USHoward Hughes Medical Institute · USUniversity of Illinois Chicago · USJackson Laboratory · US

Funding

University of Chicago Autoimmunity Center of ExcellenceU19AI082724 · NIAID · UNIVERSITY OF CHICAGO · PI CLARK, MARCUS RAMSAY · 2009 to 2023
$7.2M
Immunoglobulin and T Cell Receptor Gene AssemblyR37AI032524 · NIAID · YALE UNIVERSITY · PI SCHATZ, DAVID G. · 2007 to 2016
$3.5M
Regulation of Ig-kappa recombination during B lymphopoiesisR01AI120715 · NIAID · UNIVERSITY OF CHICAGO · PI CLARK, MARCUS RAMSAY · 2015 to 2019
$2.3M
In vivo functions of Ig-beta ubiquitinylationR01GM101090 · NIGMS · UNIVERSITY OF CHICAGO · PI CLARK, MARCUS RAMSAY · 2013 to 2016
$1.3M
Regulation of cyclin D3 in B lymphocyte developmentR01GM088847 · NIGMS · UNIVERSITY OF CHICAGO · PI CLARK, MARCUS RAMSAY · 2010 to 2013
$1.2M
Howard Hughes Medical InstituteNIAID NIH HHS AI120715NIAID NIH HHS R01 AI120715NIAID NIH HHS R37 AI032524NIAID NIH HHS U19 AI082724NIGMS NIH HHS GM088847NIGMS NIH HHS GM101090NIGMS NIH HHS R01 GM088847NIGMS NIH HHS R01 GM101090
6 · The paper itself

Abstract

B lymphopoiesis requires that immunoglobulin genes be accessible to RAG1-RAG2 recombinase. However, the RAG proteins bind widely to open chromatin, which suggests that additional mechanisms must restrict RAG-mediated DNA cleavage. Here we show that developmental downregulation of interleukin 7 (IL-7)-receptor signaling in small pre-B cells induced expression of the bromodomain-family member BRWD1, which was recruited to a specific epigenetic landscape at Igk dictated by pre-B cell receptor (pre-BCR)-dependent Erk activation. BRWD1 enhanced RAG recruitment, increased gene accessibility and positioned nucleosomes 5' to each Jκ recombination signal sequence. BRWD1 thus targets recombination to Igk and places recombination within the context of signaling cascades that control B cell development. Our findings represent a paradigm in which, at any particular antigen-receptor locus, specialized mechanisms enforce lineage- and stage-specific recombination.

Indexed as

AnimalsApoptosisBromodomain Containing ProteinsDown-RegulationHistone AcetyltransferasesImmunoglobulinsInterleukin-7MiceRecombination, GeneticSignal TransductionUp-RegulationBRD1 protein, mouseBromodomain Containing ProteinsHistone AcetyltransferasesIgKImmunoglobulinsInterleukin-7

Identifiers

PMID26301565
PMCPMC4575638
OpenAlexW2207698491

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.